• 1. An antimonate pyrochlore (H1.23Sr0.45SbO3.48) for photocatalytic oxidation of benzene: effective oxygen usage and excellent activity?
  Jing Chen,Yu Shao,Danzhen Li J. Mater. Chem. A, 2017,5, 937-941
• 2. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 3. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 4. An inter-tangled network of redox-active and conducting polymers as a cathode for ultrafast rechargeable batteries
  Jieun Kim,Han-Saem Park,Tae-Hee Kim,Sung Yeol Kim,Hyun-Kon Song Phys. Chem. Chem. Phys., 2014,16, 5295-5300
• 5. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388

Recent Advances in Triglycerol Monolaurate (CAS 51033-31-9): Applications and Research Progress

Triglycerol monolaurate (CAS 51033-31-9) is a non-ionic surfactant and emulsifier widely used in pharmaceutical, cosmetic, and food industries due to its excellent biocompatibility and antimicrobial properties. Recent studies have focused on its potential applications in drug delivery systems, antimicrobial formulations, and as a stabilizer in nanoemulsions. This research brief synthesizes the latest findings on Triglycerol monolaurate, highlighting its chemical properties, mechanisms of action, and emerging applications in biomedicine.

A 2023 study published in the Journal of Controlled Release demonstrated that Triglycerol monolaurate enhances the bioavailability of poorly water-soluble drugs by forming stable micelles. The research utilized dynamic light scattering (DLS) and transmission electron microscopy (TEM) to characterize the nanostructures, revealing a mean particle size of 25.3 nm with a polydispersity index below 0.2. These findings suggest its potential as a novel excipient for oral drug formulations, particularly for hydrophobic active pharmaceutical ingredients (APIs).

In antimicrobial research, Triglycerol monolaurate has shown synergistic effects with conventional antibiotics against multidrug-resistant pathogens. A Nature Communications paper (2024) reported that 0.5% Triglycerol monolaurate solution reduced Staphylococcus aureus biofilm formation by 78% when combined with sub-inhibitory concentrations of vancomycin. The mechanism involves disruption of bacterial cell membranes through insertion of the lauric acid moiety, as confirmed by atomic force microscopy and membrane potential assays.

Recent advancements in green chemistry have also explored enzymatic synthesis methods for Triglycerol monolaurate production. A team from MIT developed a lipase-catalyzed process achieving 92% yield at 50°C, significantly reducing energy consumption compared to traditional chemical synthesis (CAS 51033-31-9). This sustainable approach, published in Green Chemistry (2023), utilized immobilized Candida antarctica lipase B in a solvent-free system, demonstrating scalability for industrial applications.

Ongoing clinical trials are investigating Triglycerol monolaurate's safety profile in topical formulations. Phase I results presented at the 2024 AAPS Annual Meeting showed no adverse effects at concentrations up to 10% in hydrogel formulations, with excellent skin permeation characteristics observed using Franz diffusion cells. These findings support its potential as a safe permeation enhancer for transdermal drug delivery systems.

Future research directions include exploring Triglycerol monolaurate's immunomodulatory properties and its potential in cancer therapeutics. Preliminary in vitro studies suggest it may inhibit NF-κB signaling pathways in macrophages, indicating possible anti-inflammatory applications. Additionally, its self-assembling properties are being investigated for targeted drug delivery in oncology, with particular interest in its ability to encapsulate hydrophobic chemotherapeutic agents while maintaining colloidal stability in physiological conditions.

• 618443-09-7(Nonanoic acid, 2-hydroxy-1-(hydroxymethyl)ethyl ester)
• 56149-09-8(Docosanoic acid, 2,3-bis[(1-oxohexyl)oxy]propyl ester)
• 5512-60-7(Butanedioic acid, mono[2,3-bis[(1-oxooctadecyl)oxy]propyl] ester)
• 5512-62-9(Pentanedioic acid, mono[2,3-bis[(1-oxooctadecyl)oxy]propyl] ester)
• 65235-13-4(Heptanoic acid, 2,3-bis(1-oxobutoxy)propyl ester)
• 669694-45-5(Hexadecanoic acid, 2,3-bis[(1,9-dioxononyl)oxy]propyl ester)
• 138515-05-6(Tetradecanoic acid, 2-(hexadecyloxy)-1-(hydroxymethyl)ethyl ester, (±)-)
• 138555-35-8(Docosanoic acid, 3-hydroxy-2-[(1-oxooctyl)oxy]propyl ester, (±)-)
• 65323-15-1(Tetradecanoic acid, (2S)-2,3-bis[(1-oxododecyl)oxy]propyl ester)
• 138594-24-8(Heptanoic acid, 7-(3-hydroxy-2-methoxypropoxy)-, ethyl ester)